BfArM - Federal Institute for Drugs and Medical Devices

Navigation and service

Dear Doctor Letter (Rote-Hand-Brief) on Septopal® 10 Batch 11L0504 and Septopal® 30 Batch 12C0503 (gentamicin): Recall due to quality deficiency

Active substance: gentamycin

The company Biomet Deutschland GmbH is recalling the a.m. two batches due to a mix-up of the inner sachets. The company cannot rule out the possibility of lacking sterility.

Download DHPC / Information letter , Download_VeroeffentlichtAm_EN PDF, 94KB, File is accessible